In vitro evaluation of polymeric nanoparticles with a fluorine core for drug delivery triggered by focused ultrasound - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Colloids and Surfaces B: Biointerfaces Année : 2021

In vitro evaluation of polymeric nanoparticles with a fluorine core for drug delivery triggered by focused ultrasound

Résumé

Polymeric nanoparticles are being intensively investigated as drug carriers. Their efficiency could be enhanced if the drug release can be triggered using an external stimulus such as ultrasound. This approach is possible using current commercial apparatus that combine focused ultrasound with MRI to perform ultrasonic surgery. In this approach, nanoparticles made of a perfluoro-octyl bromide core and a thick polymeric (PLGA-PEG) shell may represent suitable drug carriers. Indeed, their perfluorocarbon core are detectable by 19 F MRI, while their polymeric shell can encapsulate drugs. However, their applicability in ultrasound-triggered drug delivery remains to be proven. To do so, we used Nile red as a model drug and we measured its release from the polymeric shell by spectrofluorometry. In the absence of ultrasound, only a small amount of Nile red release was measured (<5%). Insonations were performed in a controlled environment using a 1.1 MHz transducer emitting tone bursts for a few minutes, whereas a focused broadband hydrophone was used to detect the occurrence of cavitation. In the absence of detectable inertial cavitation, less than 5% of Nile red was released. In the presence of detectable inertial cavitation, Nile red release was ranging from 10 to 100%, depending of the duty cycle, acoustic pressure, and tank temperature (25 or 37℃). Highest releases were obtained only for duty cycles of 25% at 37℃ and 50% at 25℃ and for a peak-to-peak acoustic pressure above 12.7 MPa. Electron microscopy and light scattering measurements showed a slight modification in the nanoparticle morphology only at high release contents. The occurrence of strong inertial cavitation is thus a prerequisite to induce drug release for these nanoparticles. Since strong inertial cavitation can lead to many unwanted biological effects, these nanoparticles may not be suitable for a therapeutic application using ultrasound-triggered drug delivery.
Fichier principal
Vignette du fichier
HIFU_RedNileRelease_Polymer_v11_unmarked.pdf (2.41 Mo) Télécharger le fichier
supplemental_materials.pdf (415.02 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03117613 , version 1 (21-01-2021)

Identifiants

Citer

L. Somaglino, L. Mousnier, A. Giron, W. Urbach, N. Tsapis, et al.. In vitro evaluation of polymeric nanoparticles with a fluorine core for drug delivery triggered by focused ultrasound. Colloids and Surfaces B: Biointerfaces, 2021, 200, pp.111561. ⟨10.1016/j.colsurfb.2021.111561⟩. ⟨hal-03117613⟩
42 Consultations
127 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More